حقن البيتاميتازون فوسفات الصوديوم تحت الجلد كعلاج للبردة

Authors

  • قحطان جلول

Abstract

 

دراسة فعالية حقن البيتاميتازون فوسفات الصوديوم تحت الجلد لمعالجة البردة.

أجري البحث في مشفى الأسد الجامعي, جامعة تشرين, اللاذقية, في الفترة بين كانون الثاني من عام 2009 وكانون الأول عام 2010.

تضمنت الدراسة 30 مريضاً تتراوح أعمارهم بين سنة واحدة و 54 سنة لديهم بردة وتمت معالجتهم بحقن
(0.2 مل) من البيتاميتازون فوسفات الصوديوم في النسيج تحت الجلد حول البردة من قبل نفس الطبيب ودون استخدام أي مخدر موضعي, ثم تمت مراقبة المريض بعد أسبوعين من الحقن وتمت إعادة الحقن لمرة واحدة عند عدم ملاحظة تراجع في حجم البردة بعد أسبوعين من الحقن بجرعة تساوي نصف الجرعة الأولى (0.1 مل) علماً أنه تم الحقن مرتين كحد أقصى بفارق أسبوعين بينهما.

تم متابعة 30 مريضاً لديه بردة وتمت معالجتهم بحقن البيتاميتازون فوسفات الصوديوم في النسيج تحت الجلد حول البردة فكانت النتائج الآتية:

في 27 مريض (90% ) اختفت البردة عندهم بشكل تام .

في 16 مريض (53.3%) اختفت البردة عندهم بعد أول حقن, و11 مريضاً (36.7%) اختفت البردة عندهم بعد الحقنة الثانية. وبقي 3 مرضى (10%) لم يستجيبوا للمعالجة.

-حجم البردة حتى وقت الحضور إلى العيادة لم تؤثر بشكل كبير على نتيجة المعالجة .

تطور لدى مريضين فقد صباغ موضعي في منطقة الحقن, و لم تظهر أية اختلاطات أخرى .

إن استعمال حقن البيتاميتازون فوسفات الصوديوم تحت الجلد علاج بسيط وفعال للبردة ومن ناحية أخرى فإن المقارنة مع الحالة السريرية تحدد الاستطباب .

The study aims to investigate the efficacy of subcutaneous Betamethasone phosphate sodium injection in the treatment of chalazion. The research was carried out in Al-Assad Hospital, Tishreen University, Lattakia, in the period from January 2009 to December 2010.

The study included 30 patients; their age ranged between 1-54 years. The patients had chalazion treated with an injection (0.2ml) of Betamethasone phosphate sodium in the subcutaneous tissue around the lesion. All injections were given by a single ophthalmologist. No local or topical anaesthetic was used. The patients were monitored after 2 weeks. The injection (half of the first dose 0.1ml) was repeated when the chalazion did not reduce, with a maximum of two more injections given over a 2-week interval.

Thirty patients with chalazion were followed up and treated with injection of Betamethasone phosphate sodium into the subcutaneous tissue around the lesion. In 27 patients (90%), the lesion subsided completely. 16 patients (53.3%) had lesions that subsided with one injection. 11 patients (36.7%) had lesions that subsided after the second injection. 3 patients (10%) did not respond to the treatment. The size and duration of the chalazion up till the time of the patients’ visit to the clinic did not significantly affect the outcome of the treatment. Two patients developed depigmentation of the skin at the site of injection. No other major complications were encountered.

Subcutaneous injection of the Betamethasone phosphate sodium appears to be a simple and effective treatment for chalazion. Further comparative clinical cases are indicated.

Author Biography

قحطان جلول

كلية الطب البشري- جامعة تشرين- اللاذقية- سورية

Downloads

Published

2013-10-23

How to Cite

1.
جلول ق. حقن البيتاميتازون فوسفات الصوديوم تحت الجلد كعلاج للبردة. Tuj-hlth [Internet]. 2013Oct.23 [cited 2024May1];35(4). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/248

Issue

Vol. 35 No. 4 (2013): العلوم الصحية

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)

1 2 > >>